Your browser doesn't support javascript.
loading
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Gao, Wen; Wu, Lingxiang; Jin, Shidai; Li, Jun; Liu, Xinyin; Xu, Jiali; Zhang, Wei; Gong, Qixing; Sun, Chunxiao; Wang, Wei; Wang, Zidun; Shao, Yang W; Yin, Jiani C; Shen, Lu; Chen, Liang; Wang, Qianghu; Guo, Renhua.
Affiliation
  • Gao W; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wu L; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Jin S; Department of Bioinformatics, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Li J; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Liu X; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Xu J; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhang W; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Gong Q; Department of Radiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Sun C; Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wang W; Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wang Z; Department of Neurology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Shao YW; Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yin JC; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, China.
  • Shen L; School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Chen L; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, China.
  • Wang Q; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, China.
  • Guo R; Department of Thoracic Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China wangqh@njmu.edu.cn rhguo@njmu.edu.cn clbright0909@njmu.edu.cn.
J Immunother Cancer ; 10(11)2022 11.
Article in En | MEDLINE | ID: mdl-36450378
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymoma / Thymus Neoplasms / Myasthenia Gravis Limits: Humans Language: En Journal: J Immunother Cancer Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymoma / Thymus Neoplasms / Myasthenia Gravis Limits: Humans Language: En Journal: J Immunother Cancer Year: 2022 Document type: Article Affiliation country: China